Dr. Bratslavsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 E Adams St
Syracuse, NY 13210Phone+1 315-464-6106Fax+1 315-464-6117
Education & Training
Albany Medical CenterResidency, Urology, 2000 - 2005
Albany Medical CollegeClass of 2000
Certifications & Licensure
NY State Medical License 2011 - 2026
PA State Medical License 2013 - 2018
VA State Medical License 2005 - 2012- American Board of Urology Urology
Clinical Trials
- Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 11 citationsComprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma.Gennady Bratslavsky, Stephanie Gleicher, Joseph M. Jacob, Thomas Sanford, Oleg Shapiro
Urologic Oncology. 2021-03-25 - 25 citationsMolecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment.Taylor C. Remillard, Gennady Bratslavsky, Sandra Jensen-Taubman, William G. Stetler-Stevenson, Dimitra Bourboulia
Molecular and Cellular Therapies. 2014-06-03 - 373 citationsMultiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic r...Baris Turkbey, Haresh Mani, Vijay Shah, Ardeshir R. Rastinehad, Marcelino Bernardo
The Journal of Urology. 2011-11-01
Lectures
- Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Malignant pheochromocytoma (MP): A comprehensive genomic profiling (CGP) study.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- PBRM1Â mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Press Mentions
Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in the Lancet OncologyNovember 30th, 2020
Upstate Professors to Present at International Cancer Conference in SpainSeptember 27th, 2019- Cytoreductive Nephrectomy May Benefit RCC Patients with Brain MetsDecember 12th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
